Literature DB >> 10721464

The cause of invasive cervical cancer could be multifactorial.

H Haverkos1, M Rohrer, W Pickworth.   

Abstract

Cancer of the cervix is the third most common cancer among women worldwide, with incidence rates ranging from 3.8 per 100,000 women per year in Israel to 48.2 per 100,000 per year in Colombia. Epidemiologic and clinical data suggest that human papillomaviruses, especially HPV-16 and HPV-18, play the major role in the etiology of cervical cancer. However, many investigators acknowledge that HPV is neither necessary nor sufficient in the etiology of cervical cancer and that a multifactorial etiology is likely. HPV cannot be found in every patient with the disease and other factors, such as herpes simplex virus type 2 infection, cigarette smoking, vaginal douching, nutrition, and use of oral contraceptives, have been associated with cervical cancer. In two different animal models, tumors can be produced following exposure to DNA viruses and tars. Using those animal models as prototypes, we propose that the etiology of cervical cancer in humans could be an interaction between DNA viruses, specifically papillomavirus and/or HSV-2 infection, and tar exposure through cigarette smoking and/or tar-based vaginal douching.

Entities:  

Mesh:

Year:  2000        PMID: 10721464     DOI: 10.1016/s0753-3322(00)88642-4

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

1.  HIV necessary though not sufficient for AIDS.

Authors:  Harry W Haverkos
Journal:  J Biosci       Date:  2003-06       Impact factor: 1.826

Review 2.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

3.  Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.

Authors:  Paula M Ferreira; Raquel Catarino; Deolinda Pereira; Ana Matos; Daniela Pinto; Ana Coelho; Carlos Lopes; Rui Medeiros
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

4.  Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells.

Authors:  Afsoon Moktar; Rajesh Singh; Manicka V Vadhanam; Srivani Ravoori; James W Lillard; C Gary Gairola; Ramesh C Gupta
Journal:  Int J Oncol       Date:  2011-06-29       Impact factor: 5.650

5.  Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk.

Authors:  Selena Palma; Flavia Novelli; Luca Padua; Aldo Venuti; Grazia Prignano; Luciano Mariani; Renata Cozzi; Donatella Tirindelli; Antonella Testa
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-13       Impact factor: 4.553

6.  Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.

Authors:  Petr Kuglik; Jan Smetana; Vladimira Vallova; Lucie Moukova; Katerina Kasikova; Michaela Cvanova; Lucie Brozova
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.

Authors:  Yu-Fang Xia; Gui-Hua Pei; Ning Wang; Yan-Ci Che; Feng-Sheng Yu; Fu-Fen Yin; Hai-Xia Liu; Bing Luo; Yan-Kui Wang
Journal:  Virol J       Date:  2017-02-04       Impact factor: 4.099

8.  Co-carcinogenesis: Human Papillomaviruses, Coal Tar Derivatives, and Squamous Cell Cervical Cancer.

Authors:  Harry W Haverkos; Gregory P Haverkos; Michael O'Mara
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

9.  Molecular Epidemiology of High-Risk Types of Human Papillomaviruses (16, 18) in Pap-Smear, the North East of Iran.

Authors:  A Moradi; S Bakhshandeh Nosrat; S Besharat
Journal:  Iran J Cancer Prev       Date:  2011

10.  Implication of human herpesviruses in oncogenesis through immune evasion and supression.

Authors:  Kenneth Alibek; Yeldar Baiken; Ainur Kakpenova; Assel Mussabekova; Samal Zhussupbekova; Madina Akan; Bolat Sultankulov
Journal:  Infect Agent Cancer       Date:  2014-01-20       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.